Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00635791
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Malignant Solid Tumour;   Renal Cell Carcinoma;   Non Small Cell Lung Carcinoma
Interventions: Drug: Sorafenib;   Drug: Vorinostat

Indicates status has not been verified in more than two years